secondari prevent acut myocardi infarct beta-block agent calcium antagonist discoveri beta blocker use hypotens antiangin antiarrhythm properti interest clinician research pharmaceut commun addit minor differ varieti ancillari properti specul specif class drug advantag class enthusiasm report first small trial beta blocker postmyocardi infarct mortal rate commerci support necessari differ beta blocker clinic set plethora beta blocker avail studi consider improv design implement larg clinic trial appar discrep result variou trial meta-analysi indic beta blocker postinfarct mortal meta-analysi particular drug specif dose use individu patient clinic practic result individu trial conclus meta-analysi clinic util beta blocker secondari prevent myocardi infarct experiment evid calcium antagonist infarct size seri larg studi calcium antagonist effect mortal patient myocardi infarct lesson beta-block trial rapid evalu efficaci calcium antagonist set clear beta blocker calcium antagonist effect secondari prevent myocardi infarct 